These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 26077125)
1. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway. Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125 [TBL] [Abstract][Full Text] [Related]
2. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients. Chaabane S; Messedi M; Akrout R; Ben Hamad M; Turki M; Marzouk S; Keskes L; Bahloul Z; Rebai A; Ayedi F; Maalej A Inflamm Res; 2018 Aug; 67(8):703-710. PubMed ID: 29796841 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695 [TBL] [Abstract][Full Text] [Related]
4. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population. Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028 [TBL] [Abstract][Full Text] [Related]
5. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986 [TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Bohanec Grabar P; Logar D; Lestan B; Dolzan V Eur J Clin Pharmacol; 2008 Nov; 64(11):1057-68. PubMed ID: 18607581 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111 [TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. Taraborelli M; Andreoli L; Archetti S; Ferrari M; Cattaneo R; Tincani A Clin Exp Rheumatol; 2009; 27(3):499-502. PubMed ID: 19604445 [TBL] [Abstract][Full Text] [Related]
9. MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate. González-Mercado MG; Rivas F; Gallegos-Arreola MP; Morán-Moguel MC; Salazar-Páramo M; González-López L; Gámez-Nava JI; Muñoz-Valle JF; Medina-Coss Y León R; González-Mercado A; Aceves MA; Dávalos NO; Macías-Chumacera A; Dávalos IP Genet Test Mol Biomarkers; 2017 Nov; 21(11):698-704. PubMed ID: 28994615 [TBL] [Abstract][Full Text] [Related]
10. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis. Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563 [TBL] [Abstract][Full Text] [Related]
11. Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients? Ghodke Y; Chopra A; Joshi K; Patwardhan B Clin Rheumatol; 2008 Jun; 27(6):787-9. PubMed ID: 18274813 [TBL] [Abstract][Full Text] [Related]
12. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients. Saleh MM; Irshaid YM; Mustafa KN Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443 [TBL] [Abstract][Full Text] [Related]
14. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation. Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520 [TBL] [Abstract][Full Text] [Related]
15. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients. Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758 [TBL] [Abstract][Full Text] [Related]
16. Association of MTHFR C677T, MTHFR A1298C, and MTRR A66G Polymorphisms with Neural Tube Defects in Tunisian Parents. Nasri K; Midani F; Kallel A; Ben Jemaa N; Aloui M; Boulares M; Lassoued M; Ben Halima M; Ben Wafi S; Soussi M; Mahjoubi I; Baara A; Ben Fradj MK; Omar S; Feki M; Jemaa R; Gaigi SS; Marrakchi R Pathobiology; 2019; 86(4):190-200. PubMed ID: 31238314 [TBL] [Abstract][Full Text] [Related]
17. Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Shao W; Yuan Y; Li Y Genet Test Mol Biomarkers; 2017 May; 21(5):275-285. PubMed ID: 28277784 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. Ranganathan P; Culverhouse R; Marsh S; Mody A; Scott-Horton TJ; Brasington R; Joseph A; Reddy V; Eisen S; McLeod HL J Rheumatol; 2008 Apr; 35(4):572-9. PubMed ID: 18381794 [TBL] [Abstract][Full Text] [Related]
19. Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis. Lee YH; Song GG Clin Drug Investig; 2010; 30(2):101-8. PubMed ID: 20067328 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Berkun Y; Levartovsky D; Rubinow A; Orbach H; Aamar S; Grenader T; Abou Atta I; Mevorach D; Friedman G; Ben-Yehuda A Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]